A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

GLP-1 class of weight loss and diabetes drugs are linked to previously unrecognized health risks and benefits, according to a ...

But then Golden turned to glucagon-like peptide 1 (GLP-1) receptor agonists ... obesity — a BMI of ≥ 40 — has increased from 7.7% to 9.7% of US adults. The number of joint replacements ...

One common diet question among people taking these drugs, which include Ozempic or Mounjaro for type 2 diabetes and Wegovy or Zepbound for obesity, is: Can I drink on a GLP-1? The short answer is ...

(Photo by: Michael Siluk/UCG/Universal Images Group via Getty Images) For those who are overweight or obese, medications known as glucagon-like peptide-1 agonists ... about 4.7 million U.S ...